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The amphiphilic nature of saponins and their
eﬀects on artiﬁcial and biological membranes
and potential consequences for red blood and
cancer cells
Joseph H. Lorent,*a,b Joëlle Quetin-Leclercqb and Marie-Paule Mingeot-Leclercqa
Saponins, amphiphiles of natural origin with numerous biological activities, are widely used in the
cosmetic and pharmaceutical industry. Some saponins exhibit relatively selective cytotoxic eﬀects on
cancer cells but the tendency of saponins to induce hemolysis limits their anticancer potential. This
review focused on the eﬀects of saponin activity on membranes and consequent implications for red
blood and cancer cells. This activity seems to be strongly related to the amphiphilic character of saponins
that gives them the ability to self-aggregate and interact with membrane components such as cholesterol
and phospholipids. Membrane interactions of saponins with artiﬁcial membrane models, red blood and
cancer cells are reviewed with respect to their molecular structures. The review considered the mecha-
nisms of these membrane interactions and their consequences including the modulation of membrane
dynamics, interaction with membrane rafts, and membrane lysis. We summarized current knowledge
concerning the mechanisms involved in the interactions of saponins with membrane lipids and examined
the structure activity relationship of saponins regarding hemolysis and cancer cell death. A critical analysis
of these ﬁndings speculates on their potential to further develop new anticancer compounds.
Introduction
Several reviews have characterized the biological and pharma-
cological eﬀects36 of saponins, and some have specifically con-
sidered saponin eﬀects on membranes,7 their hemolytic
activity, and their activity on cancer cells.8,125 Nevertheless,
there is a lack of reviews linking the amphiphilic character and
other molecular specificities of saponins with their eﬀect on
membranes and resulting pharmacological and pharma-
ceutical consequences.
In the present review we examined the amphiphilic charac-
ter of saponins and their ability to self-aggregate and reviewed
the ability of saponins to interact specifically with membrane
lipids. We further described their eﬀects on diﬀerent mem-
brane models, including monolayers and bilayers. A brief
section covers in silico models with saponin activity. Finally,
we examined diﬀerent aspects of saponin-induced hemolysis
and cancer cell death, including cytolysis, apoptosis, and
autophagy.
Definition and role of saponins in nature
Saponins, which are found in plants and certain other organ-
isms, are known for their multiple pharmacological activity.173
The name saponin originates from the Latin word “sapo”
(soap) and describes the surfactant character of saponins and
their ability to produce foam. Many saponin-containing plants
have therefore been used traditionally as soaps.16 Although the
role of saponins in plants is not suﬃciently understood, they
seem to serve primarily as defensive molecules.119 Many sapo-
nins are toxic to insects, fish, fungi, bacteria, plants, parasites,
and mammals.24,36,112,116,155,162,168,173 In holothurians and
star fish, saponins are repulsive or toxic to predators.162,173
The indiscriminate use of the word “saponin” in the litera-
ture is potentially confusing: the term is sometimes used to
refer to a specific saponin (for example α-hederin) or it may be
used to describe a mixture of saponins extracted from a plant.
The commercial Merck saponin (saponin pure white, Saponi-
num album) is a crude saponin fraction obtained from roots
and rhizomes of Gypsophila paniculata L. Because diﬀerent
“saponin” manufacturers use non-identical plants to extract
the saponin fraction, research results must be compared with
caution. To avoid confusion, we use the trademarked term
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“saponin®” to designate crude extracts from diﬀerent manu-
facturers and the general terms “saponin” and “saponins” to
refer to any non-commercial molecule. Similarly, Quillaja sapo-
nins isolated from the Quillaja saponaria Molina. bark can be
obtained in diﬀerent degrees of purity. “Quil-A” is a purified
aqueous extract of the bark.108,150 Other fractions with higher
saponin content exist. For example, QS-21 is a fraction of Quil-A,
purified by reverse phase chromatography.122 We refer to all
such extract types as “Quillaja saponins”.
The amphiphilic structure of saponins
Structurally, saponins are amphiphilic compounds composed
of one or more hydrophilic sugar parts and a lipophilic steroid
or triterpenic part (sapogenin) (Fig. 1). Other substances that
are structurally closely related to saponins, such as cardiotonic
heterosides or glycoalkaloids, are sometimes referred to as
saponins. Because their structures and eﬀects on membranes
are similar, these substances are treated equally. Saponins are
classified into monodesmosidic, bidesmosidic, and polydes-
mosidic saponins according to the number of sugar chains—
one, two, or more, respectively. A wide structural variety of
saponins can be found in nature due to the presence of
diﬀerent sugars, sugar branchings, and sapogenins. The most
common sugars are D-glucose, L-rhamnose, D-galactose, D-glu-
curonic acid, L-arabinose, D-xylose, and D-fucose. Cardiotonic
heterosides and glycoalkaloids also contain other types of
sugars. Several books and reviews on naturally occurring
saponin structures can be referred.16,33
Saponin behavior at hydrophobic–
hydrophilic interfaces
The behavior of saponin molecules at hydrophobic–hydro-
philic interfaces and subsequent physical consequences are
critical for their activity and will be discussed hereunder.
Accumulation at hydrophobic–hydrophilic interfaces
The air–water interface is the most common hydrophobic–
hydrophilic interface. Most saponins are water-soluble thanks
to their polar sugar component. Depending on their solubility,
some saponins are dissolved as monomers whereas others
accumulate at the air–water interface with their hydrophilic
head oriented to the waterside and their hydrophobic tail
oriented to the airside (Scheme 1A) This behavior reduces the
surface tension of water by decreasing the number of hydrogen
bonds per length.64 Many saponins are known as water surfac-
tants (Table 1).14,67,102,122,128,174 Quillaja saponins are able to
build a highly elastic monolayer with their hydrophobic triter-
penic tail pointing to the airside.147
The eﬀects of saponins on lipid monolayers adsorbed at the
air–water interface are discussed in a later section.
Saponins as surface-active agents
Because of their “biosurfactant” ability, saponins are often
used in the pharmaceutical, cosmetic, and food industry.
Fig. 1 Left: A steroid pentacyclic saponin (furostanol type). Right: A tri-
terpenoid pentacyclic saponin (oleanane type). The saponin is either
monodesmosidic or bidesmosidic depending on the number of sugar
chains (one or two chains, respectively). R1 and R2 are usually ramiﬁed
sugars, bound via an ether or ester link. Scheme 1 Behavior of saponins in aqueous solution.
Table 1 Eﬀects of saponin at interfaces
Eﬀect Techniques
Type of
interaction Consequences Saponin Ref.
Adsorption at
the air–water
interface
Tensiometry Saponin/
air–water
surface
Reduction in water
surface tension, foam
forming ability
Soyasaponins, Anchusosides,
Glycyrrhizin, Digitonin,
Hederacolchiside, α-Hederin,
Hederacoside C, β-Escin,
β-Sitosterol, Ginsenoside Rg2,
Glycyrrhizinic acid, Primulic
acid
14,67,102,122,128,147,174
Adsorption at
other
interfaces
Tensiometry, viscosity
measurements,
miscibility tests, quasi-
elastic light scattering
Saponin–air
interface
Reduction of
interfacial tension,
stabilization of (nano)
emulsions or (nano)
suspensions
Quillaja saponins, Yucca
saponins, Ginsenosides,
Acetylated aescin, Extract of
Sapindus mukorossi
9,17,28,147,159
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Saponins are able to stabilize emulsions (emulsifiers) because
of their ability to reduce interfacial energy between diﬀerent
phases (hydrophobic–hydrophilic) (Table 1). Many cosmetics
(creams, lotions, and milks147,159) contain saponins as emulsi-
fiers. In soaps and shampoos, saponins are used to reduce the
surface tension of water to stabilize the formation of foam.9
Saponins have the potential to stabilize nanosuspensions
and nanoemulsions, which are biphasic systems containing
very small droplets (<100 nm). They show numerous interest-
ing pharmacological and pharmaceutical properties including
a decrease of hemolysis28 or an increase of the immune
response to antigens.17
Formation of amphiphilic aggregates
(micelles and other nanoscaled
objects) by saponins
At the critical micelle concentration (CMC), saponins form
aggregates in solution that remain in equilibrium with free
monomers whose concentration does not exceed the CMC
(Scheme 1B and C). These molecular aggregates are “soft” or
fluid-like structures because intermolecular forces are weak
and limited to hydrogen bonds and van der Waals, hydro-
phobic, or screened electrostatic interactions. Micelles are
regarded as three-dimensional molecular aggregates. They are
generally spherical in shape although other forms of aggre-
gates can be produced by self-aggregation or inter-aggregate
interactions. The presence of diverse amphiphilic species
favors the complexity of these structures, which can be con-
sidered as nano-objects if they present a limited size of
1–100 nm in one or more dimensions. According to the British
standard commission, micelles and ISCOMs® (see hereunder)
are nanoparticles because they are nanoscaled in all three
dimensions.15 Nano-objects may form a visible precipitate that
is sometimes regarded as an “insoluble complex” in the litera-
ture; nanoparticles with a defined aggregation number and
size are not visible with the naked eye and can be considered
“soluble”.64
In the pharmaceutical and healthcare sector, research on
nanoparticles and nano-objects is characterized by their wide
range of possible applications in areas such as cardiovascular
diseases, musculoskeletal, neuro-degenerative and psychiatric
disorders, cancer, diabetes mellitus, and bacterial and viral
infections.124 The shape and chemical composition of nano-
particles and nano-objects can be purposely modified to
enhance the pharmacokinetic and pharmacodynamic pro-
perties of drugs and imaging agents. Nanoparticles and nano-
objects can be used to increase drug concentrations in tar-
geted cells or tissues, thus improving the eﬃcacy133 and redu-
cing the toxicity by inhibiting the interaction with sensitive
tissues.21 Additionally, an increased immunogenic response
can be achieved.100 The self-aggregating properties of saponins
therefore constitute a promising research area that involves the
formation of completely new nano-objects and nanoparticles.
Self-aggregation of saponins
The formation of micelles is observable with many saponins
(Table 2).9,14,25,103–105,131,174 For example, micelles composed
of a highly purified fraction of Quillaja saponins are spherical
with an aggregation number of 65 and a diameter of 3–7 nm.
The CMC of these micelles increases with temperature as well
as with ionic strength. The micelle size also increases with
temperature.103–105,131,145 Other saponins such as ginsenoside
Ro are able to form vesicles of 30–50 nm, and ginsenoside Rb1
and Rg1 interaggregate species of spherical micelles. Mixtures
of saikosaponins and ginsenoside Rb1 induce the formation of
worm-like micelles.25
Aggregation of saponins with sterols
Mixed molecular aggregates of finite size that are composed of
more than one amphiphilic species (i.e. saponins and sterols)
are often mixed micelles (Table 2). Quillaja saponins are able
to form mixed micelles with cholesterol and therefore enhance
the solubility of the sterol by a factor of 1000. These micelles
are larger than pure saponin micelles (10 nm versus 7 nm) and
have a higher aggregation number and CMC. Cholesterol is
part of the lipid compartment of the micelle.103–105 Demana
et al. observed the formation of worm-like micelles for
diﬀerent saponin/cholesterol proportions.30 Saponins of Sapo-
naria oﬃcinalis L., Quillaja saponaria Molina., and Glycine max L.
are also able to form micelles of rod-, worm-, or spherical
shape with bile acids.143
In addition to soluble mixed micelles, insoluble complexes
composed of sterols and saponins have also been described
(Table 2). Sterols are able to form water insoluble complexes
with digitonin called digitonides.52,53,62 α-Tomatine and the
α-chaconine–α-solanine mixture are able to form insoluble
complexes with sterols. α-Tomatine has the ability to form
complexes that are quite similar to those of digitonides. The
aglycone tomatidine lacks this ability.126 Alfalfa saponins
(extracted from Medicago sativa L.) form insoluble complexes
with cholesterol that are dissociable in pyridine.6 We showed
that α-hederin is able to interact with cholesterol to form an
insoluble precipitate in a buﬀer solution at pH = 7.4.97
The direct interaction of saponins with cholesterol and the
subsequent complexation or formation of micelles has a
potential application in the development of drugs against
hypercholesterolemia (Hypercholesterolemia increases the
risk of developing cardiovascular diseases). Because of their
amphiphilic character, saponins are likely able to influence
micelle formation between sterols and bile acids, which is
necessary for sterol absorption. Digitonin, alfalfa saponin, and
Quillaja saponins16 potentially form insoluble complexes with
cholesterol in the intestinal lumen and could therefore reduce
cholesterol absorption. Karaya root saponins are known to
interact preferentially with bile salts, which are necessary for
micelle formation, thereby decreasing cholesterol absorption.2
Some saponins may have the ability to transform into phyto-
sterols through hydrolytic enzymes in the lumen. They could
therefore act as prodrugs for phytosterols, whose cholesterol
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lowering properties are well known.70,92 In contrast, tiqueside
and pamaqueside, two synthetic saponins, inhibit the trans-
port of cholesterol from the lumen through the enterocyte brush
border membrane by acting on unknown protein targets.31,107
Simultaneous aggregation of saponins with sterols and
phospholipids and the formation of pharmacologically active
nanoparticles
For some saponins, coincubation with phospholipids and
sterols produces a wide variety of aggregates, including hexago-
nal and cubic phases, bilayers, rod-like, helical, and worm-like
micelles, and the formation of increasingly complex structures
such as immune stimulating complexes (ISCOMs®) (Fig. 2 and
Table 2).64,64,65,108 These structures have shown huge adjuvant
potential and could be used in the formulation of vaccines.
Their formation depends primarily on the preparation mode
used. Consequently, some structures seem to be metastable
and transform into other structures.29,30,108 Because a multi-
tude of saponins and lipids is present in some extracts used to
prepare the nanoparticles (especially in Quillaja saponins), it
is often diﬃcult to identify which molecules are present in
these 3D structures and to determine the interactions between
them.30,71,108,118,151 ISCOMs® are cage-like complexes of 40 nm
in diameter.56 Electron microscopy observations revealed that
ring-like micelles can aggregate into ISCOMs®. Based on this
observation, Kersten and Crommelin proposed their model for
the structure of ISCOMs® in which one building block is equal
to one ring-like structure.29,71,108,118 Under certain conditions,
ISCOMs® can have a shelf-life of several years.56
Some research groups prepared ISCOM®-like structures
containing diﬀerent types of lipids and saponins. Modified
ISCOMs® (Posintro™), which contain DC-cholesterol (dimethy-
laminoethane-carbamoyl-cholesterol) instead of cholesterol,
have a reduced negative particle charge and have been shown
to pass through the skin. These modified ISCOMs® could
potentially be used to immunize the organism through a trans-
dermal patch applied to the skin.99
Cucumarioside A2 from marine macrophytes forms tubular
nano-objects (called “tubular ISCOMs®”), which improve the
immunogenicity by a factor of four.75
In addition to the formation of ISCOM®-like structures,
other types of nano-objects can be prepared from mannosy-
lated saponins based on oleanolic and glycyrrhizic acids.
Transmission electron microscopy (TEM) has shown the for-
mation of ring-like micelles, rod-like tubular structures, and
helical and thread-like micelles.26 An ethanol red ginseng root
extract incubated with cholesterol and phosphatidylcholine
produced ginsomes, spherical nanoparticles with a diameter
of 70–107 nm. These ginsomes, which are mainly composed of
ginsenoside Rb2, Rc, Rb1, and Rd, were able to stimulate the
immune response.146,178 Nanoparticles from Quillaja saponins
preferentially induced apoptosis in cancer cells and were less
hemolysis-inducing than pure extracts.56
Eﬀects and interactions of saponins
with membrane models
Following our description of how saponins interact with
diﬀerent membrane components in a hydrophilic environment,
this section emphasizes saponin interactions in artificial mem-
brane models. Membranes provide an amphiphilic environment
that can be described by a hydrophobic gradient increasing
from the hydrophilic interfacial domain to the hydrophobic
core. Studies on the eﬀects of saponins using artificial mem-
brane models have generated valuable data concerning the
interactions of these molecules with diﬀerent membrane com-
ponents in an amphiphilic environment. These studies further
provide insight into the mechanism of membrane lysis.
Interaction with supported monolayers
One of the most common ways to investigate interactions
between exogenous compounds and lipid membranes relies
on supported monolayers (Langmuir–Blodgett films), films of
water-insoluble lipids floating on the water surface (Scheme 1).
A two-dimensional monolayer is comparable to a three-dimen-
sional gas system. Diﬀerent phases of the monolayer can be
observed by increasing the lipid density or lipid coverage
(Scheme 2). Before its collapse, the monolayer successively
Fig. 2 Transmission electron microscopy of cage-like ISCOM® matrices
(solid arrow), helices (dashed arrow), and double helices (dotted arrow)
(bar = 100 nm).108 Scheme 2 Diagram of surface pressure versus area isotherm.
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passes through a gaseous state, a liquid expanded state, a
liquid compressed state, and a solid state. The phase coexis-
tence is sometimes detectable, for example the liquid
expanded and the liquid compressed state. Monolayers serve
as valuable models to demonstrate the insertion of saponins
as well as their eﬀect on phase separation and the formation
of domains.
Insertion of saponins into monolayers. Some saponins
(Table 3) are able to insert into diﬀerent types of monolayers
in the absence of cholesterol.4,46,113 For α-tomatine, however,
insertion into a monolayer has only been observed in the pres-
ence of cholesterol.148 This insertion is eﬀective only when the
hydroxyl function in position 3 of the sterols present in the
monolayers is in β.148 In addition, insertion is pH-dependent
because nitrogen protonation of the glycoalkaloid increases
dissolution in the aqueous phase.166 For glycyrrhizin, insertion
is dependent on the monolayer surface pressure. At concen-
trations higher than the CMC of saponin, the molecule
accumulates mainly in the space just below the monolayer.130
Induction and interaction with phase separation. Expand-
ing on investigations of saponin insertion, Brewster angle
microscopy has revealed the formation of domains in mono-
layers composed of DMPC and selected sterols incubated with
α-tomatine.148,166 The authors suggest that these domains are
mainly composed of sterol-glycoalkaloid complexes. Although
domains in monolayers can be considered 2D micelles, the
CMC required for domain formation in monolayers is reduced
by a factor of 10 compared with the CMC needed to form
micelles in solution.64,129 Consequently, the formation of
saponin-sterol aggregates (or even of self-aggregation) could be
facilitated in a lipid environment.
A ternary model composed of DOPC/palmitoylsphingomye-
lin/cholesterol (1 : 1 : 1, molar ratio) was used to investigate the
eﬀects of glycyrrhizin on lipid phase separation. At concen-
trations below its CMC, glycyrrhizin reduced the size of raft
domains. Above the CMC, the appearance of striped regions
devoid of phospholipids suggested the formation of mem-
brane defects, which could be responsible for membrane
permeabilization.130
Interaction with bilayer models
Bilayer models, which are a better approximation of biological
membranes than monolayers, have been used extensively to
explore the eﬀects of saponins on membranes. It is possible to
monitor the eﬀects on supported planar bilayers (SPB), black
lipid membranes, liposomes (multi-lamellar vesicles [MLV],
large unilamellar vesicles [LUV], giant unilamellar vesicles
[GUV], and small unilamellar vesicles [SUV]).
Binding to membranes composed of phospholipids. Few
studies have investigated the interaction between saponins
and bilayers composed of phospholipids. Digitonin and
desglucodigitonin can be bound by equilibrium binding
(no full insertion) to membranes composed solely of egg
yolk phosphatidylcholine.113 In the corresponding studies,
α-hederin was able to reduce the surface potential of mem-
branes composed of DMPC, suggesting that it binds to the
membrane. This binding most probably occurred through the
interaction between the negatively charged carboxylic function
on the triterpenic ring structure and the positive charge of
DMPC.97
Binding to membranes containing phospholipids and
cholesterol. In a model of egg yolk phosphatidylcholine and
cholesterol, the formation of an equimolar complex induced a
permanent insertion of digitonin into the membrane.113 The
study proposed three essential steps for binding of digitonin
to membranes containing cholesterol and phospholipids.
First, with increasing digitonin/cholesterol ratios, digitonin
and cholesterol formed “aggregated” species in the membrane.
Second, at higher molar ratios, an intermediate complex was
composed of a mixture of equimolecular complexes and aggre-
gated species. Third, an equimolecular complex formed in the
bilayer.3 Glycoalkaloids were found to bind to membranes
exclusively in the presence of cholesterol. Results also
suggested the formation of an equimolecular complex of
sterols and glycoalkaloids.72
Eﬀects on membrane lipid dynamics. Lipids in a membrane
are in constant motion (flip–flop, rotation, etc.) characterized by
diﬀerent correlation times (Scheme 3). A variety of techniques,
such as 2H-NMR, EPR, fluorescence spectroscopy, and fluo-
rescence probes, can be used to obtain information concerning
membrane order at diﬀerent time scales and membrane levels.
A lipid bilayer may be present in diﬀerent states depending
on the environmental temperature and lipid composition: a
fluid-like state, termed the liquid crystalline phase (Lα), is
associated with high lipid mobility and low order. Conversely,
a solid-like state or gel phase (Lβ) shows reduced lipid motion
and high order. Cholesterol has a well-known influence on
lipid dynamics because of its rigid ring structure; it reduces
gauche–trans isomerization, the rotational and lateral diﬀusion
of lipids, which results in an ordering eﬀect on the liquid crys-
talline state.127,132 The rigid ring structure of cholesterol pos-
sesses a planar side (α-side) and a “rough” side (β-side). The
β-side forces lipids in the gel state to occupy a larger surface
area. A fluidizing eﬀect in the gel state is thus observed.93,96,127
We anticipate that the possible interaction of saponins with
cholesterol in membranes could considerably influence the
dynamic parameters of a membrane. The rigid ring structure
of saponin, which is very similar to that of sterols, should
itself have a significant eﬀect on membrane dynamics even
when no interaction with cholesterol is present. The present
review is, however, limited to studies performed at tempera-
tures where membranes are in the liquid crystalline (or liquid
ordered) state because all mammal membranes must be con-
sidered as “fluids”.42
In the absence of cholesterol, the lateral diﬀusion of fluo-
rescent phosphatidylethanolamine4 was slightly reduced, an-
isotropy for fluorescently labeled lipids and DPH97,98 generally
increased, the EPR order parameter of phospholipids3,37,113
increased, and the 2H-NMR order parameter of labeled phos-
pholipids3 decreased.
In the presence of cholesterol, the anisotropy of fluore-
scently labeled lipids as well as the EPR and the 2H-NMR order
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parameters of labeled phospholipids and cholesterol were
generally reduced.3,97,113
The diﬀerent acquisition time scales (ns to μs) of these
techniques explain the diﬀering order parameters between
results obtained by EPR or fluorescence spectroscopy and
NMR. EPR and fluorescence spectroscopy work in 10−9–10−8 s.
On this time scale, the main observations are gauche–trans
isomerization (10−10 s) and rotational diﬀusion (10−8 s)
(Scheme 3), which are clearly reduced by saponins in the
absence of cholesterol, or increased by saponins in the pres-
ence of cholesterol. The ordering eﬀect of cholesterol seems to
be inhibited by saponins. 2H-NMR works in 10−5 s. A reduced
order parameter suggests that lipid motions corresponding to
correlation times of 10 ns–10 µs increase regardless of the
cholesterol content.
Eﬀect on lateral organization of membrane lipids. The
lateral organization of lipids into domains has become a
recognized concept in cell membrane biology.93 At high
cholesterol concentrations, saturated phospholipids, sphingo-
lipids, and sterols are able to segregate from lipids presenting
non-saturated acyl chains (Ld, Lα or liquid crystalline phase)
and form domains of a new lipid phase: the Lo phase or liquid
ordered phase. In addition to its ordering eﬀect (see above),
cholesterol has a condensing eﬀect that reduces the lateral
space occupied by lipids and increases the membrane thick-
ness of domains (Lo phase). The Lo phase can be considered
as an intermediate between Lα and Lβ.
Because some saponins are able to form aggregates with
cholesterol in 3D and 2D systems (see above), we expect these
saponins to have an eﬀect on the lateral organization of the
membrane. The following three examples are in agreement
with this assumption. The saponin®-enabled solubilization of
alkaline phosphatase (a protein present in the Lo phase) by
Triton X-100 that occurs in liposomes containing cholesterol
but not in liposomes that only contain sphingolipids suggests
cholesterol dependent domain disruption.134 We demon-
strated the ability of α-hederin to form worm-like domains
with increased intrinsic curvatures in membranes containing
cholesterol and partial segregation of cholesterol and phos-
pholipids.98 Lastly, the cofactor for the acrosome reaction-
inducing substance (Co-ARIS), a steroidal monodesmosidic
saponin, was able to co-localize and provoke the expansion of
ganglioside-GM1 clusters.111
Permeabilizing activity. Numerous studies have shown that
cholesterol is a key factor in saponin-induced membrane per-
meabilization. For most saponins (Table 3) cholesterol was
identified as an enhancing or necessary factor in permeabiliza-
tion.4,46,72,89,97,98,113 Nevertheless, for some saponins (Table 3),
especially bidesmosides, cholesterol was an inhibiting or
unnecessary factor in membrane permeabilization.57,89 We
therefore assume that several mechanisms may lead to per-
meabilization. Published data on the diﬀerent modes of action
of monodesmosidic and bidesmosidic saponins can be sum-
marized as follows.
Mechanisms involved in saponin-induced membrane per-
meabilization. In 1962, Bangham et al. observed hexagonal
structures exclusively in cholesterol-containing planar mem-
branes incubated with saponin®. They proposed a micellar
arrangement of saponins and cholesterol in the membrane
that resulted in the formation of a pore corresponding to the
observed hexagonal structures (Scheme 4).10 Other mecha-
nisms, summarized in the following, have since been
suggested.
Three principal mechanisms for monodesmosidic saponins
have been described.
First, the saponin interaction with sterols led to equimole-
cular complexes in the membrane as observed for mono-
desmosidic glycoalkaloids (presenting sugar residues at C3).
When these complexes reached a certain density, hydrophilic
interactions between the sugar moieties induced the formation
of a new lipid phase and the three-dimensional shape of the
sterol-glycoalkaloid complexes then determined the formation
of new spherical buds or tubules. Membrane disruption
occurred as a consequence of membrane rearrangement.72 Glyco-
alkaloid-induced tubular aggregates have also been observed
by other teams.34
Second, a mechanism based on the formation of toroidal
pores was established in a POPC/DOPE/Chol model for avena-
cin A1, a monodesmosidic triterpenoid saponin. The hydro-
philic interaction between the sugar moieties first led to an
aggregation of saponins and cholesterol and further caused
the formation of pores.4
Scheme 3 Approximate correlation times of lipid motion in
membranes.42
Scheme 4 Micellar rearrangement of saponin with cholesterol in the
membrane as proposed by Bangham et al.: Cholesterol ( ), saponin
( ). The central speckled area represents the pore.10
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Third, for α-hederin, we discovered a concentration-depen-
dent permeabilization mechanism that is based on the aggre-
gation with sterols and phospholipids and an induced
membrane curvature in GUVs (Scheme 5). A curvature-depen-
dent permeabilization had also been proposed for dioscin, as
simulation suggests (see in silico models).91 At concentrations
below their CMC, α-hederin monomers bound to the external
monolayer (Scheme 5A). The created area diﬀerence and curva-
ture between the outer and the inner monolayer induced vesi-
culation (Scheme 5B). Further aggregation of saponins,
cholesterol, and phospholipids led to the formation of worm-
like aggregates in the membrane (Scheme 5C), which were
responsible for transient defects and a gradual permeabiliza-
tion. Domain formation and permeabilization speed increased
with the size of the sugar chain attached at C3 of the tri-
terpenoid ring.97,98 At concentrations exceeding the CMC,
α-hederin induced direct pore formation in the membrane
(Scheme 5D) and caused the loss of membrane material
(Scheme 5E), suggesting that micelles (or aggregates) were able
to directly interact with the membrane and deliver high
amounts of saponins close to the membrane.
Binding to cholesterol-enriched domains led to immediate
membrane permeabilization and formation of increasingly
macroscopic pores. α-Hederin was more likely to accumulate at
the rim of the pore and stabilize it by reducing line tension
because of its amphiphilic character. This model supposes the
induction of a positive curvature strain on the external mono-
layer. The two hydrophilic sugars gave an axe-like shape to the
saponin and the molecule therefore induced positive curvature
stress in a transbilayer direction, which led to the formation of
macroscopic pores or worm-like aggregates. This model takes
into account the concentration dependent self-aggregating pro-
perties of the saponin,14 its three-dimensional shape, its
aﬃnity for cholesterol, and its amphiphilic character.97,98
Nevertheless, further investigation of the correlation between
the permeabilizing eﬀect and the self-aggregating properties is
necessary.
In contrast to what was observed for monodesmosidic sapo-
nins, cholesterol was thought unnecessary for membrane per-
meabilization by avicin D, a bidesmosidic saponin. This
saponin did not completely destabilize the membrane; it
formed stable pores (∼1.1 nm), which presented a certain
selectivity towards the ion charge that depended on the phos-
pholipid composition of the membranes,89 suggesting an
interaction of avicin D with phospholipids. Other bidesmosi-
dic saponins displayed a similar behavior.57
Structure–activity relationship (SAR) studies. The diﬀerent
modes of action (see the previous paragraph) and the fact that
most SAR studies describe hemolysis and the lytic eﬀect on
living cells, not on artificial models, make it diﬃcult to estab-
lish a structure–activity relationship of the membrane permea-
bilizing activity of saponins. Despite this diﬃculty some
general rules can be formulated regarding the permeabilizing
activity of monodesmosidic saponins.
A special polar sugar group in C3 is necessary to induce
curvature and consequent pore formation. This prerequisite
could favor interactions with sterols in membranes by shield-
ing the hydrophobic sterol ring from water (umbrella eﬀect).97
Other studies suggest that the formation of pores is accele-
rated by hydrophilic–hydrophilic sugar interactions between
saponins.4,72
In addition, some SAR studies compared important struc-
tural features of the membrane sterol regarding the permeabi-
lization induced by monodesmosidic saponins. The hydroxyl
function at position C3 in β, the alkene function in C5 and C6,
and the side chain at C17 (for a limited number of carbons)
increased the membrane permeabilizing activity.72,123
In silico models of saponin-lipid and
saponin-membrane interactions
In silico models allowed us to hypothesize how saponins could
be able to interact with membrane constituents or membranes
at a molecular level (Table 4). Although such studies can never
replace experiments on membrane models, they can explain
and underline experimental data.
Some studies have simulated the molecular interactions of
saponins with sterols and phospholipids based on a minimum
interaction energy model. Dioscin, a monodesmosidic
saponin, preferentially binds to cholesterol in a hydrophobic
environment. Therefore, cholesterol extraction from the
Scheme 5 Model of the membrane interaction for α-hederin, a mono-
desmosidic triterpenoid saponin. At concentrations lower than the CMC,
α-hederin monomers bind to cholesterol (A) and induce vesiculation (B)
and lateral phase separation (C). At concentrations higher than the CMC
(D), α-hederin aggregates provoke pore formation and the loss of mem-
brane material (E).97,98
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membrane with dioscin seems unlikely. Although the inter-
action between the hydroxyl group in cholesterol and the sugar
present in dioscin is most probable, however a “head to tail”
interaction cannot be excluded.91 Other saponins bind to
sterols by superposing their hydrophobic rings.72,114
Further studies have investigated the simultaneous inter-
action of saponins with sterols and phospholipids, proposing
a ternary structure composed of phospholipids, saponins, and
cholesterol for glycoalkaloids and α-hederin.72,98
In parallel to these studies, valuable data have been
obtained through in silico models that were able to simulate
the activity of saponins on an entire membrane. A Monte-
Carlo simulation (big layer) that mimicked a 2D monolayer
composed of α-hederin, cholesterol and DMPC showed that
α-hederin preferentially partitions between phospholipids and
cholesterol and favors large aggregates of cholesterol in the
membrane.98 A coarse-grained molecular dynamics simulation
of a DPPC-POPC-PSM-Chol lipid bilayer showed that dioscin
accumulates in membrane rafts and increases their membrane
curvature. This curvature causes membrane disruption.91 The
proposed mechanism is very similar to observations made for
α-hederin using membrane models (see above).
Eﬀects of saponins on red blood cells
Considering the critical role of cholesterol in membrane per-
meabilization, red blood cells constitute an ideal model
because they are characterized by a high cholesterol amount in
the plasma membrane.5,55 In addition, red blood cells lack a
nucleus and several intracellular organelles and are therefore
simpler models than other eukaryotic cells.
Many saponins are known for their hemolytic eﬀect, and
several studies investigating lysis of red blood cells have been
performed. Presented here are selected examples (Table 5) of
studies that analyzed the mechanisms of saponin-hemolysis.
Table 4 In silico models of saponin/lipid and saponin/membrane interaction
Eﬀect Techniques
Type of
interaction
Cholesterol
presence
in model Consequences
Cholesterol
dependency Saponin Ref.
Cholesterol/
saponin/
phospholipid
interaction
Molecular
modeling
Saponin/
cholesterol
Yes Superposing of
hydrophobic rings
Yes Dioscin 91
Saponin/
cholesterol/
phospholipid
Yes Possible ternary complex Yes Glycoalkaloids
α-Hederin
72,98,114
Aggregation in
monolayer
Monte Carlo
simulation
Saponin/
cholesterol/
phospholipid
Yes Partition between
cholesterol and
phospholipids and
aggregation of cholesterol
Yes α-Hederin 98
Pore formation in
bilayer
Molecular
dynamics
simulation
Saponin/
cholesterol/
phospholipid
Yes Induction of curvature in
raft models
Yes Dioscin 91
Table 5 Eﬀect of saponins on red blood cells
Techniques
Type of
interaction Consequences
Cholesterol
dependency Saponin Ref.
TEM, freeze-fracture EM,
ferritin labeling,
hemoglobin release
Saponin/? Increasing defects
(holes), protein release
? Merck pure saponin, Alfalfa
saponin
12,135,136,142
Microscopy, measurements
of membrane fluctuation
Saponin/
cytoskeleton-
membrane
ATP independent shape
transformation into
ghosts
? Saponin® (pure white) 12,88,144
Hemoglobin release,
tensiometry
Surfactant
activity
No clear correlation
between surfactant and
hemolytic activity
? Monodesmosides and
bidesmosides
14,51,128,137,165
Amphipath cholesterol
activation, variation of
cholesterol content of
erythrocytes or media
Saponin/
cholesterol
Aggregation with
cholesterol leads to
hemolytic activity
Yes Quillaja saponins, α-Hederin,
Dioscin, Timosaponin A-III,
β-escin, Saikosaponin d,
Holotoxin A
81,82,156
Cholesterol depletion of
erythrocytes
Saponin/
cholesterol
No clear correlation
between cholesterol
amount and hemolytic
activity
No Digitonin, Styrax saponin A, 138,139
Aescin, Smilagenyl-β-maltoside,
Tigogenyl-β-maltoside, Styrax
sapogenin-A
Inhibitors of glycosidases,
saponin extraction from
lysed cells
Saponin/
membrane
glycosidases
Hydrolysis of saponin
into sapogenin by
contact with erythrocytes
No Digitonin, Tomatine, Solanine,
Styrax saponin-B, Glycyrrhizin
138,140
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Despite the number of studies available, certain issues
regarding saponin-induced hemolysis remain controversial. In
the following, we oﬀer an extensive discussion of these issues.
Morphological description of hemolysis
Although frequently neglected, the morphological description
of saponin-induced hemolysis could potentially contribute to
valuable information regarding saponin activity. Levin and
Korenstein reported that erythrocytes treated with saponin®
transformed into “ghost” cells. These erythrocytes lost their
biconcave shape and became spherical; a process that could
not be reversed with adenosyl triphosphate (ATP).88 This irre-
versible transformation of shape, which was not accompanied
by any important changes in membrane elasticity, could
occur because of a disturbance in membrane cytoskeleton
interactions.12,144
At the nanoscopic level, transmission electron microscopy
has revealed the presence of long-lasting holes or pits in red
blood cells incubated with saponins and the formation of
multi-lamellar stacks composed of crystallized lipids of the
membrane.12,142 Pits were uniformly distributed and had a
diameter of 4–5 nm. The authors predicted the consequent
development of bigger holes or larger defects,136 as was
demonstrated with α- and δ-hederin for GUVs.97 The develop-
ment of larger pores would be consistent with the saponin-
induced release of proteins from the cytoplasm.12,135
Possible correlation between hemolytic and surfactant activity
Many studies suggested a correlation between surfactant and
hemolytic activities for some saponins.14 Nevertheless, no
clear correlation has yet been established;51,128,137,165 we can
thus dismiss the hypothesis that hemolysis is driven solely by
a detergent-like mechanism.
The role of membrane cholesterol
The importance of membrane cholesterol in hemolysis is
uncertain and remains a subject of debate. Some studies
indirectly indicate that saponins aggregate with cholesterol.
Added to media, cholesterol was able to inhibit saponin hemo-
lysis, suggesting that the saponin was “complexed” by the
sterol.156 Furthermore, several amphipaths were able to dis-
place cholesterol from phospholipids and thus increased the
hemolytic potency of Quillaja saponins.81,82 This finding is,
however, in disagreement with studies led by Segal et al. who
suggested that cholesterol does not serve as a specific binding
site for saponins because no clear relationship between cell
cholesterol amounts and hemolysis was established.138,139
Importance of the sugar residue for hemolysis
For monodesmosidic saponins containing a glucose residue,
Segal et al. found that the hemolytic activity of aglycones is
similar to that of their corresponding saponin. They concluded
that saponins, before becoming eﬀective, are first cleaved into
their sapogenin by glycosidases (glucosidases or galactosi-
dases).138,140 This conclusion contradicts other results that
showed that several sapogenins (oleanolic acid, gitogenin,
hederagenin, and others) had no hemolytic eﬀect. Surpris-
ingly, preincubation of red blood cells with sapogenins even
inhibited saponin-induced hemolysis. Inhibition of saponin
hemolysis was also achieved when erythrocytes were preincu-
bated with other non-hemolytic saponins.22,41,51,158,170
It is therefore unlikely that glycosidases are necessary to
“activate” the hemolytic potency of all saponins. Some genins
may nevertheless possess their own permeabilizing activity.
Interestingly, we were able to demonstrate the permeabiliza-
tion of GUVs by hederagenin for very long incubation times
(48 h).98 This eﬀect is consistent with observations of hemoly-
sis for diﬀerent aglycones and might be dependent on the
interaction with phospholipids.98,138,140
Structure–activity relationships
Although the hemolytic activity of saponins has been investi-
gated by several SAR studies, their diﬀerences in protocols and
types of erythrocytes make it diﬃcult to compare results. We
summarized the results of studies that tested a large number
of saponins under identical conditions (Fig. 3). Some studies
comparing the activities of steroid versus triterpenoid saponins
showed that steroid saponins induce faster hemolysis.157
Even if their surfactant activity increased, bidesmosidic
(sugar residue at C3 and C28) triterpenoids or steroid saponins
were in most cases less hemolytic than monodesmosidic sapo-
nins.51,128,165,170 Some general enhancing properties are sum-
marized in Fig. 4.
Toxicological drawbacks due to saponin hemolysis
Excessive saponin-induced hemolysis can lead to anemia cul-
minating in death.149 The pharmacological use of saponins is
only feasible if they can be excluded from causing significant
hemolysis or if they do not pass into the blood stream.
Research and synthesis of hemolysis-free saponins is therefore
crucial. Understanding the mechanisms involved in saponin
Fig. 3 SAR studies on the hemolytic activity of monodesmosidic sapo-
nins.22,41,158,165,170 Magenta: structural features that enhance the hemo-
lytic activity. Blue: structural features that inhibit the hemolytic activity.
R1: Sugars are necessary for hemolytic activity. The residue (α-L-Rha-
(1→2)-α-L-Ara) results in high hemolytic activity. For some genins,
activity increases with the number of sugars. The activity changes when
sugar branching changes. If the number of sugars is constant, α-L-
Rha→β-D-Glc (1→2), (1→4), and (1→6) are more active than (1→3). R2:
Triterpenoid saponins (–OH enhances activity). Steroid saponins, dio-
sgenin (–OH and alkane chains reduce activity, except –COC5). R3: Triter-
penoid saponins (–COOH and esteriﬁcation of COOH increase activity).
Note that certain chemical functions exclude the presence of others.
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hemolysis and the implications of molecular features could
facilitate the synthesis of high-activity and low-toxicity com-
pounds. Gauthier et al. showed that, in comparison with olea-
nane type saponins, lupane-type saponins have a very low
tendency to induce hemolysis combined with an increased
ability to induce apoptosis in cancer cells.41 As previously
stated, the formation of saponin nanoparticles may oﬀer an
interesting solution to reducing the hemolytic activity of sapo-
nins by maintaining or increasing their activity towards cancer
cells. The following section examines the eﬀect of saponins on
cancer cells.
Eﬀects of saponins on cancer cells
In contrast to red blood cells, eukaryotic cells possess a
nucleus and intracellular organelles. These subcellular com-
partments are separated from the cytoplasm by membranes
that have diﬀerent compositions in lipids and proteins. The
cholesterol content of membranes of diﬀerent organelles is
very variable,163,171 which could explain the specificity of
some saponins towards a certain type of organelle. As we
have previously shown, saponin eﬀects are not restricted to
membrane lysis because saponins can influence the dynamics
or lateral organization of membranes. All these eﬀects can
lead to the activation or inhibition of membrane proteins
or even induce signaling pathways causing programmed cell
death.19,43,85,90,120,175,177
Eﬀect on dynamic properties of the lipid membrane
Under physiological conditions, mammalian cellular mem-
branes are always in the fluid state.42 It should therefore be
possible to compare results concerning membrane dynamics
with the eﬀect of saponins on artificial membranes in the
liquid crystalline (or liquid ordered) state. The modulation of
dynamic membrane properties in cells can have multiple
eﬀects on membrane proteins and cell metabolism.49,63,80
In many cases, the eﬀects of saponins on the dynamic pro-
perties of artificial membranes are dependent on the chole-
sterol content (see above). Because the cholesterol content
varies considerably between cell types and organelles, the
modulation of order parameters may vary (Table 6) accord-
ingly. For example, ginsenoside Rg3 reduced the fluorescence
anisotropy of DPH and TMA-DPH in multidrug resistant cells
only. This decrease correlated with a decrease in resistance
towards adriamycin.80 Other saponins increased or decreased
diﬀerent order parameters in diﬀerent cell types independent
of their lytic potential.49,63,68,117 Ginsenoside Re significantly
reduced the micro viscosity of DPH in mitochondria isolated
from rat brains. This reduction might explain the protective
eﬀect of ginsenoside against cerebral-ischemia injury because
mitochondria play an important role in ROS production and
subsequent lipid peroxidation.179
Eﬀect on lateral membrane organization (interaction with rafts)
Cell membrane rafts are very heterogenous, functional lateral
domains of 10–200 nm enriched with cholesterol and sphingo-
lipids and unstable in time. These domains also contain glyco-
sphingolipids and GPI-anchored proteins and are platforms
for protein signal transduction. Their disruption or aggre-
gation may induce pathways leading to programmed cell death
and may produce other eﬀects.66,93 In some types of cancer
cells (especially prostate cancer), lipid rafts have higher amounts
of cholesterol compared with non-malignant cells,121,180 which
could make them interesting targets for saponin activity.
The disruption of rafts has various eﬀects on cell mem-
branes such as receptor activation or changes in ion channel
permeability (Table 6).13,18,54,60,110,134,141,160,181 The transloca-
tion of some receptors or membrane proteins to rafts and the
disruption of rafts upon treatment with diﬀerent saponins was
confirmed by confocal or biphoton microscopy. Ginsenoside
Rh2 and avicin D both induced such an eﬀect, leading to
apoptosis activation through the extrinsic pathway (Scheme 6,
blue pathway).68,120,175,177 Co-ARIS, which is a saponin cofactor
for the acrosome reaction inducing substance, was able to
alter the lateral cholesterol distribution in sperms and dis-
rupted the caveola system in CHO-K1 cells.111
Cell death induced by saponins
Diﬀerent kinds of saponin-induced cell death including cell
lysis, necrosis, apoptosis, and autophagy (Scheme 6 and
Table 6) have been observed. Cell lysis and necrosis both
include the destruction of the plasma membrane. Apoptosis
and autophagy are programmed cell deaths; they are induced
via various stimuli and executed through specific pathways. To
classify this saponin-induced cell death, it is particularly
important to describe the occurring morphological changes
and provide biochemical evidence.39,78
Morphological features of saponin-induced cell death.
Treatment with diﬀerent saikosaponins resulted in various
manifestations in Ehrlich ascite tumor cells (Fig. 5). Minor
structural changes can induce major changes in the morpho-
logical appearance.1 The main morphological features induced
by saponins are (1) the formation of “blebs” (Fig. 5b),1,40
which are classical hallmarks of necrosis and apoptosis11,78
but may also be direct consequences of saponin membrane
interactions, as shown for GUVs,97,98 (2) the size increase or
Fig. 4 SAR studies on the hemolytic activity of bidesmosidic sapo-
nins.165,170 Magenta: structural features that enhance hemolytic activity.
R1 = at least 1 sugar, R2 = COOH, CH2OH (needed), R3 = if 1 sugar is
present there must be at least 3 sugars in R1. Highest hemolytic activity
is obtained with 4 sugars and R1 = 1 sugar.
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disappearance of microvilli (Fig. 5c–f ) and other changes
in membrane topology such as the formation of a
granular surface (Fig. 5d and e),40,68,102,152 and (3) the for-
mation of intracellular vesicles.152 These vesicles could corre-
spond to autophagic vacuoles, or to a direct eﬀect on the
membrane.35,73
Saponin induced necrosis and membrane lysis. Character-
istics of necrosis are an increase in cellular volume, the for-
mation of blebs, the destruction of the plasma membrane,
and the release of the cytoplasm into the surrounding environ-
ment. These changes are accompanied by the activation of
Ca2+-dependent enzymes that are able to lyse the cytoskeleton
(Scheme 6, grey pathway).11,78,161
Saponin membrane lysis and saponin-induced pore for-
mation produce osmotic swelling terminating in membrane
rupture (Scheme 6, pink pathway). Both cell deaths are inter-
connected because saponin-induced pore formation may
increase intracytosolic Ca2+, activate Ca2+-dependent enzymes
and necrosis (Scheme 6, grey pathway). It is unclear whether
regulated necrosis or necroptosis is induced by saponins
because data on RIP1 and RIP2 (receptor interacting proteins 1
and 2) have not yet been published.39
Direct membrane lysis provoked by saponins can occur very
rapidly at high saponin concentrations.97,102 Electron microscopy
Scheme 6 Pathways of known saponin-induced cancer cell membrane lysis, necrosis, and apoptosis and their connections to membrane activity.
Pink pathway: pore formation and direct membrane lysis.41,44,45,47,102,115,164,172 Grey pathway: necrosis induced by pore formation and increased
Ca2+ inﬂux.161 Green pathway: apoptosis induced by direct permeabilization of the outer mitochondrial membrane.50,86,89 Orange pathway: apopto-
sis induced by the increase of intracellular calcium, reactive oxygen species production (ROS), activation of the permeability transition pore complex
(PTPC), and mitochondrial outer membrane permeabilization (MOMP).20,153 Blue pathway: apoptosis induced through raft activity and activation of
death receptors.68,120,175,177
Fig. 5 Scanning electron microscopy of Ehrlich ascite tumor cells. (a)
Control. (b) Cells treated with saikosaponin a (large protrusions: blebs).
(c) Saikosaponin b1 (longer microvilli than in control). (d) Saikosaponin
b2 (coral reef-like surface). (e) Saikosaponin c (blebs and microvilli). (f )
Saikosaponin d (disappearance of microvilli).1
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revealed the formation of holes larger than 1 µm after only
2 minutes of incubation with 10 µM hederacolchiside A1
(Fig. 6).
Similarly, oleanane-type saponins rapidly induced the per-
meation of small hydrophilic molecules such as calcein and
propidium iodide in cancer cells.41,45 Saponins either induced
pores whose size increased with concentration and time171 or
pores large enough to produce a fast release of LDH and other
proteins.44,47,102,172 It is possible to visualize saponin®-induced
pores in fibroblasts84 by AFM. The ability of saponins to
rapidly induce large holes in plasma membranes makes them
useful tools for the immunohistochemistry of intracellular
proteins.102,115,164
Interestingly, tetrandrine (a bisbenzylisoquinoline) increased
the size of Quillaja saponin-induced pores. This ability was
neither observed with digitonin nor with ginseng saponins; we
therefore suppose that tetrandrine interacts specifically with the
pore formed by Quillaja saponin.87
Some studies investigated the cholesterol dependence of
membrane permeabilization. Membrane lysis and cell death of
monocytic cells induced by α-hederin decreased when mem-
brane cholesterol was depleted.97 For MEL-5 cells, Tof-SIMS
analysis revealed no colocalization of cholesterol and hedera-
colchiside A1 when pores formed after 2 min of treatment.
After 30 min of incubation, hederacolchiside A1, phospholi-
pids, and cholesterol seemed to aggregate in the same
areas.102 This behavior is similar to observations of GUVs incu-
bated with α-hederin, where cholesterol and phospholipids
aggregated in the same domains.98
Lysis of cell organelles. Saponins showed a certain degree of
specificity regarding lysis of diﬀerent organelles (Table 6).
Brain microsomes derived from the plasma membrane and
treated with saponin® showed ring-like micellar structures.
This was not observed in the cardiac sarcoplasmic reticulum.
Microsomes derived from the endoplasmic reticulum were
more resistant to saponin® lysis than vesicles derived from
plasma membranes.61 In muscle cells, β-escin and saponin®
were able to permeabilize the traverse tubular system.83 Avicins
were able to perforate the outer mitochondrial membrane and
thus induced the release of cytochrome c, which led to inhib-
ited respiration and the induction of apoptosis.86
The susceptibility of diﬀerent organelles to Gypsophila sapo-
nins correlated with the cholesterol/phospholipid ratio of their
membranes (plasma membrane > lysosomal membrane >
Golgi membrane > outer mitochondrial membrane > inner
mitochondrial membrane > endoplasmic reticulum).171
Apoptosis. Morphologically, apoptosis leads to the conden-
sation of chromatin, the fragmentation of the nucleus, the for-
mation of membrane blebs, and the existence of apoptotic
bodies.11,78 Apoptosis is mediated by two major pathways, the
intrinsic and the extrinsic pathway.69
Although numerous papers have investigated saponin-
induced apoptosis, our review concentrated on studies examin-
ing apoptosis in direct relationship with the membrane inter-
action (Table 6). An elucidation of every discovered pathway is
beyond the scope of this review.
The intrinsic pathway. The intrinsic pathway depends pri-
marily on the disruption of the external mitochondrial mem-
brane and the release of proapoptotic proteins such as
cytochrome c from the intermembrane space to the cytosol,
which can be achieved by permeabilizing the outer mitochon-
drial membrane.77 In contrast to the internal membrane, the
external mitochondrial membrane presents a high content of
cholesterol.
The intrinsic pathway induced by some avicins most prob-
ably results from direct pore formation in the outer mitochon-
drial membrane and the release of cytochrome c into the
cytosol (Scheme 6, green pathway).50,86,89
Both α-hederin and macranthoside B provoked an increase
in reactive oxygen species (ROS) and an extracellular Ca2+
influx, leading to the opening of the permeability transition
pore complex (PTPC)58,59,76 and to apoptosis (Scheme 6,
orange pathway).20,27,47,97,153 The depletion of membrane
cholesterol inhibited α-hederin-induced apoptosis (data not
published). ROS production might also be a consequence of
direct mitochondrial membrane activity and act as an apopto-
sis amplifier.169
The extrinsic pathway. The extrinsic pathway is activated by
membrane death receptors present in lipid rafts.32,43 Disorgan-
ization of these rafts can thus lead to an activation or inhibition
of membrane death receptors, as was established for avicin D
and ginsenoside Rh2 (Scheme 6, blue pathway).68,120,175,177
Autophagy. Autophagic cell death is accompanied by cyto-
plasmic vacuolization, causing the cell to auto digest. The
major proteins involved in this process are beclin 1, ATG5, and
LC3. Unfortunately, saponin® can cause the formation of struc-
tures that resemble GFP-LC3 puncta (a hallmark of autophagy)
in HeLa cells. It has been shown that these structures are a
consequence of non-specific protein aggregation induced by
the saponin and can therefore not be considered as a hallmark
of autophagy.23
However, some saponins were able to induce autophagy as
a protective mechanism against apoptosis (listed in Table 6).74,154
In contrast, avicin D induced autophagic cell death when
apoptosis was inhibited.176
Fig. 6 Scanning electron microscopy: control MEL-5 cells (a, b),
appearance of holes after 2 min of treatment with hederacolchiside A1
(c, d).102
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Cancer treatment potential of saponins. The described
eﬀects on cell lysis, necrosis, apoptosis, and autophagy suggest
that saponins could be potential candidates for cancer treat-
ment. Furthermore, ginsenosides and other saponins were able
to reduce cell growth by inhibiting proteins involved in the cell
cycle (cyclins or cyclin-dependent kinases) and also inhibited
other important cancer promoting pathways.48,79,94,95,109,167
Moreover, several saponins induced cell death via multiple
mechanisms (apoptosis, necrosis, and autophagic cell death)
and pathways (ROS, activity on organelles, permeabilization of
the outer mitochondrial membrane), which could potentially
prevent resistance development and increase treatment eﬃcacy.
In addition, saponins have shown specific cytotoxicity
towards cancer cells73,101,153 and the formation of saponin-
containing nanoparticles could enhance the selectivity towards
cancer cells and reduce their hemolytic potential, which could
increase their therapeutic index.56
Finally, saponins could be used to overcome chemothera-
peutic resistance to other therapeutic agents. The involvement
of cholesterol in cancer progression as well as cancer resist-
ance106,121 is well known. Cholesterol-enriched rafts are known
to promote cancer, and an accumulation of cholesterol in mito-
chondria leads to chemotherapeutic resistance.106 The specific
interaction of some saponins with cholesterol and the dis-
ruption of lipid rafts led to apoptosis in cancer cells.38,121,177
Conclusions
This review summarized the results of studies investigating the
physicochemical properties of saponins and their eﬀects on
membrane components, artificial membrane models, erythro-
cytes, and cancer cells.
Their molecular structure composed of osidic polar parts
and apolar parts gives saponins an amphiphilic character.
Saponins are able to reduce the interfacial (or surface) tension
between phases of diﬀerent polarity and stabilize emulsions or
foams. Some saponins also possess the ability to self-aggregate
into diﬀerent types of aggregates.
The molecular structure of several saponins allows them to
interact with lipid membrane components like phospholipids
and cholesterol. Interaction and mutual aggregation can lead
to the formation of several types of aggregates, such as nano-
particles and other nano-objects, which could be used in vacci-
nation or cancer therapy.
The interaction with membranes has been studied in silico
and in artificial models as well as in erythrocytes and cancer
cells.
The ability of saponins to modulate the dynamic properties
of bilayers on diﬀerent time scales is primarily sterol-depen-
dent. In cancer cells, this can lead to a decreased resistance to
chemotherapeutic agents or prevent viral infections.
Moreover, saponins show the ability to change the lateral
organization of bilayers and the disruption of lipid rafts, pro-
voking the activation of death receptors in cancer cells and
other raft dependent proteins.
The mechanism by which saponins are able to permeabilize
membranes is to a large extent structure-dependent. Although
the permeabilizing activity of monodesmosidic saponins relies
on the presence of cholesterol, as was demonstrated in both
artificial models and cancer cells, some bidesmosidic sapo-
nins do not seem to require sterols to exert their permeabiliz-
ing eﬀect. In silico studies and artificial models have shown
that the three-dimensional structure and the presence of
sugars at C3 in monodesmosidic saponins favor the sterol
interaction and induce the membrane curvature, leading to
pore formation and the transformation of the bilayer into non-
bilayer structures. In artificial models and cells, saponin
induced the aggregation of both cholesterol and phospho-
lipids. The in silico formation of a ternary complex composed
of saponins, phospholipids, and cholesterol also predicted
this behavior. The critical micellar concentration of a saponin
influences further its permeabilizing ability.
Hemolysis of saponins has been studied extensively. Never-
theless, the subject remains controversial, and further investi-
gation is especially needed to clarify the role of membrane
cholesterol and the importance of the sugar chain. It is poss-
ible that some aglycones exhibit hemolytic activity. This possi-
bility is reinforced by the fact that hederagenin showed
permeabilizing activity on GUVs.
Cell death induced by saponins can in some cases be corre-
lated with their permeabilizing activity, but in addition to
causing direct membrane lysis, many saponins induce apopto-
sis and autophagy or inhibit the cell cycle and the proliferation
of cells. Apoptosis is in some cases a direct consequence of the
activity of saponins on membranes. The extrinsic pathway is
induced subsequent to the activation of death receptors and
the reorganization of lipid rafts; the intrinsic pathway is
induced via the release of proapoptotic proteins from the inter-
membrane space of mitochondria.
However, the ability of saponins to directly target proteins
involved in cell death must be taken into account. The multi-
tudes of mechanisms by which saponins act on cancer cells
and the ability of saponins to overcome chemotherapeutic
resistance make them interesting candidates for cancer research.
We provided an overview of the complexity of saponin
activity, which is strongly dependent on their molecular struc-
ture and physicochemical properties. As our understanding of
the numerous interactions of saponins with membranes and
their resulting consequences improves continually—in particu-
lar thanks to studies on membrane models and the integration
of biophysical concepts—further investigation of these fasci-
nating compounds will certainly contribute additional valu-
able data, expanding their potential to act on cancer cells and
other targets.
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